2010 Archive

SynCo Bio Partners and Versartis Expand Collaboration as Lead Product Enters into Clinical Trials

Posted: 29/07/2010

Amsterdam, the Netherlands, July 29, 2010 - SynCo Bio Partners B.V. today announced an extension of its successful collaboration with Versartis, Inc. following the recent initiation of a Phase 1 clinical trial in type 2 diabetes mellitus (T2DM) patients with monthly dosing of VRS-859.

SynCo Expands Agreement with OncoMed Pharmaceuticals to Manufacture Cancer Stem Cell Antibodies

Posted: 03/05/2010

Amsterdam, the Netherlands, May 3, 2010 – SynCo Bio Partners B.V., an award winning GMP biopharmaceutical manufacturer, has expanded its current agreement with OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics that target cancer stem cells.

SynCo Bio Partners Signs New Manufacturing Agreements to supply the US Market; Securing its Position as a Market Leader in Micro

Posted: 02/02/2010

Amsterdam, the Netherlands, February 2, 2010 - SynCo Bio Partners B.V. today announced that it has signed two commercial manufacturing agreements with an undisclosed US biopharmaceutical company.

News & Events